Show results for
Refine by
T Cell Suppliers Serving Estonia
155 companies found
Premium
based inDueren, GERMANY
Since 2005, NIPPON Genetics EUROPE has stood for innovation and quality in biotechnology. In these two decades, we have evolved from a supplier of high quality Japanese technologies to a developer of our own groundbreaking solutions. Our products ...
Enables long term cell storage at -80°C or -196°C. Improved cell recovery and viability after thawing. Ready-to-use freezing media – no programmed or sequential freezing required. Serum-free – no risk of contamination. GMP ...
based inSeattle, WASHINGTON (USA)
AVM Biotechnology is developing and advancing AVM0703, a proprietary formulation of concentrated dexamethasone. This formulation permits the very high dosing necessary to activate the release and trigger the production of the body’s supercharged ...
AVM0703 Induces & Mobilizes Gamma Delta+ NKT-Cells. AVM0703 triggers the production and release of gamma delta+ Natural Killer T-cells (AVM-NKT). These supercharged immune cells ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Viewing cancer through the immune lens (immuno-oncology) has led to the most promising advancements in cancer treatment in recent history, nonetheless the full potential of the approach is as yet ...
based inFarmingdale, NEW YORK (USA)
ALA Scientific Instruments, Inc. began as Adams and List Associates Ltd. in 1986. ALA Scientific Instruments provides a wide range of products and services for electrophysiology research, including intracellular, extracellular, and patch recordings. ...
based inAmsterdam, NETHERLANDS
Founded in 1997, Kiadis Pharma is a fully integrated biopharmaceutical company committed to developing innovative, personalized, next-generation cell-based immunotherapies for patients with life threatening diseases. With headquarters in Amsterdam, ...
Transformative antibodies from our platform. Our discovery platform enables us to develop fully human therapeutic antibodies for the treatment of immune-related diseases. Therapies using monoclonal antibodies have proven to be effective in several ...
based inUtrecht, NETHERLANDS
At LAVA, we are focused on applying our expertise in gamma-delta T cell engagers. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor ...
We have achieved preclinical proof-of-concept with LAVA-051 by demonstrating efficacy and safety in a variety of preclinical models. LAVA-051 uniquely activates both Vγ9Vδ2 T cells as well as invariant ...
based inFreiburg, GERMANY
Dermagnostix, a spin-off company, emerged from the collaborative efforts of the Hahn-Schickard Institut, the Helmholtz Zentrum München, and TU Munich, leveraging decades of sophisticated research in dermatology, immunology, bioinformatics, and ...
LymphX, a gene expression-based test, will enable the differential diagnosis of mycosis fungoides (MF), psoriasis, and eczema. Accurate and early diagnosis is needed to improve patients’ quality of life and overall life ...
based inAmsterdam, NETHERLANDS
Sanquin employs people working in many different disciplines, including donor assistants, doctors, pharmacists, researchers, laboratory technicians and production staff. Sanquin has a Supervisory Board responsible for the overall monitoring of the ...
Our proprietary technology for UV-induced MHC-peptide exchange is ideally suited for high-throughput screening of peptide-binding to the MHC class I complexes. Moreover, combinatorial coding enables fast finding of relevant peptide-specific ...
based inPleasanton, PENNSYLVANIA (USA)
10x Genomics is building tools for scientific discovery that reveal and address the true complexities of biology and disease. 10x Genomics products have been adopted by researchers around the world, including all of the top 100 global research ...
Consistent results: Reduce variability in single cell data, generating reproducible and consistent results. Maximum lab productivity: Free up hands-on time for other experiments with walk-away convenience for single cell workflows. Integrated and ...
based inNew York, NEW YORK (USA)
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build ...
A multicenter Phase 2 trial of SL-701 in adult patients with second-line glioblastoma multiforme (GBM) has been completed, and data suggest that SL-701 is generating a target-specific CD8+ T-cell response, which may ...
based inSalt Lake City, UTAH (USA)
Echelon Biosciences, Inc (EBI) was founded as Echelon Research Labs by two professors from the University of Utah. Their initial goal was to advance the science of lipid signaling by developing novel research reagents, assays, and ultimately ...
based inWest Sacramento, CALIFORNIA (USA)
Founded in 1985, GeminiBio serves the global biotechnology industry, from basic research to commercial production, with a focus on helping our customers accelerate the development of life-enhancing biotherapeutics by streamlining and improving their ...
GemCell Plus Xeno-Free Human Serum AB enables advanced therapy researchers and developers to streamline their workflow, allowing them to bring their end products to market quickly by providing human serum that is scalable, free of bovine components, ...
based inDaxing District, CHINA
Beijing Challen Biotechnology Co., Ltd. (Challenbio) is a leading Chinese flow cytometer manufacturer, located in Biomedical Base of Daxing District, Beijing. It is a high- technology company specializing in R&D, production and sales of biomedical ...
Our product production process strictly follows relevant standards and undergoes multiple rigorous tests to ensure product quality. We pay great attention to details and use a rigorous attitude to ensure the smooth progress of your experiment or ...
based inChatham, NEW JERSEY (USA)
Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. At Tonix, we are focused on ...
TNX-1500 is a humanized monoclonal antibody (mAb) directed against CD40-ligand, which is also known as CD154, T-BAM, 5c8 antigen, TRAP and gp39. TNX-1500 incorporates the antigen binding fragment (Fab) region of hu5c8 (recombinant monoclonal ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Precision NanoSystems is a global leader in technologies, solutions and services for the development of non-viral delivery of genomic medicines, including mRNA vaccines and therapeutics. We work with the world’s leading drug developers to understand ...
based inShanghai City, CHINA
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ('Fosun Pharma'; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates ...
based inHørsholm, DENMARK
We are an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. We have developed our AI-immunology core technology to deeply understand the biological ...
RAVEN combines the essential AI tools from our PIONEER platform with structural bioinformatic tools from EDEN to arrive at a novel potent T- and B-cell vaccine design for emerging and mutating viral ...
based inCambridge, MASSACHUSETTS (USA)
Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...
Emerging from the Company’s proprietary ATAK™ CAR receptor library, Myeloid’s novel in vivo engineering platform specifically targets and activates myeloid cells to elicit broader anti-tumor adaptive immunity. Through this ...
based inRizhao, CHINA
Shandong Jiejing Group Corporation (hereinafter referred to as the company) was founded in 1968 and is now an enterprise group integrating food additive, cosmetic ingredients, dental impression material, marine biology, health products, textile ...
based inHayward, CALIFORNIA (USA)
Novodiax is dedicated to advancing tissue-based diagnostics and immunoassays through innovation. Our signature technology platform is a proprietary polymer-based detection system. Based on this technology we have developed a series of highly ...
Cluster of Differentiation 20 (CD20) is a polymerized horseradish peroxidase (pHRP)-labeled anti-CD20 (R272) rabbit monoclonal antibody intended for laboratory use using frozen or formalin-fixed-paraffin-embedded tissues. CD20 also known as ...